GA HB1035 | 2023-2024 | Regular Session
Status
Spectrum: Moderate Partisan Bill (Republican 5-1)
Status: Engrossed on February 7 2024 - 50% progression, died in chamber
Action: 2024-02-29 - Senate Read Second Time
Text: Latest bill text (Comm Sub) [PDF]
Status: Engrossed on February 7 2024 - 50% progression, died in chamber
Action: 2024-02-29 - Senate Read Second Time
Text: Latest bill text (Comm Sub) [PDF]
Summary
A BILL to be entitled an Act to amend Article 3 of Chapter 13 of Title 16 of the O.C.G.A., relating to dangerous drugs, so as to expand the exemption of naloxone from the definition of a dangerous drug to include any opioid antagonist when used for drug overdose prevention; to amend Chapter 4 of Title 26 of the O.C.G.A., relating to pharmacists and pharmacies, so as to authorize the board of pharmacy to regulate the sale and supply of opioid antagonists through vending machines; to provide that practitioners may dispense and supply opioid antagonists to certain individuals and entities; to repeal the requirement that an opioid antagonist must have a prescription in order for a individual who administers it to have civil, criminal, and professional immunity; to provide immunity for harm reduction organizations that supply opioid antagonists to certain individuals; to provide for related matters; to repeal conflicting laws; and for other purposes.
Title
Pharmacies; board regulates sale and supply of opioid antagonists through vending machines; authorize
Sponsors
Rep. Sharon Cooper [R] | Rep. Lee Hawkins [R] | Rep. Devan Seabaugh [R] | Rep. Doug Stoner [D] |
Rep. Katie Dempsey [R] | Sen. Kay Kirkpatrick [R] |
Roll Calls
2024-02-07 - House - Passage: House Vote #438 (Y: 163 N: 0 NV: 4 Abs: 11) [PASS]
History
Date | Chamber | Action |
---|---|---|
2024-02-29 | Senate | Senate Read Second Time |
2024-02-27 | Senate | Senate Committee Favorably Reported By Substitute |
2024-02-08 | Senate | Senate Read and Referred |
2024-02-07 | House | House Passed/Adopted |
2024-02-07 | House | House Third Readers |
2024-01-31 | House | House Committee Favorably Reported |
2024-01-29 | House | House Second Readers |
2024-01-26 | House | House First Readers |
2024-01-25 | House | House Hopper |